Quality of Life of Brain Tumour Patients
作者： Chiara Zucchella , Marta Maschio , Veronica Villani , Andrea Pace
DOI:
关键词:
摘要: Health-related quality of life (HRQOL) has recently become an important outcome measure in neuro-oncology. At present, no single gold standard tool exists to HRQOL and there are clear data on the role different determinants their changes during course disease brain tumour (BT) pa- tients. measures may be helpful evalu- ating cancer care outcomes also have been evaluated as early independent predic- tors survival. The negative influence several clinical factors such cognitive impairments, mood disorders, epilepsy reported studies but needs better defined. Moreover, advan- ced end-of-life phase patients still remains a neglected issue. objective this review is examine recent literature focusing most relevant issues Eur Assoc NeuroOncol Mag 2012; 2 (3): 118-22.
kup.at 参考文章(55)
J Dancey, B Zee, D Osoba, M Whitehead, F Lu, L Kaizer, J Latreille, JL Pater, Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy Quality of Life Research. ,vol. 6, pp. 151- 158 ,(1997) , 10.1023/A:1026442201191
Guy Pelletier, Marja J. Verhoef, Nasreen Khatri, Neil Hagen, Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. Journal of Neuro-oncology. ,vol. 57, pp. 41- 49 ,(2002) , 10.1023/A:1015728825642
C A Meyers, M A Weitzner, A D Valentine, V A Levin, Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology. ,vol. 16, pp. 2522- 2527 ,(1998) , 10.1200/JCO.1998.16.7.2522
Christina A Meyers, Kenneth R Hess, WK Alfred Yung, Victor A Levin, None, Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma Journal of Clinical Oncology. ,vol. 18, pp. 646- 650 ,(2000) , 10.1200/JCO.2000.18.3.646
A Coates, V Gebski, D Signorini, P Murray, D McNeil, M Byrne, J F Forbes, Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology. ,vol. 10, pp. 1833- 1838 ,(1992) , 10.1200/JCO.1992.10.12.1833
Neil K. Aaronson, Martin J.B. Taphoorn, Jan J. Heimans, Tjeerd J. Postma, Chad M. Gundy, Guus N. Beute, Ben J. Slotman, Martin Klein, Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma Journal of Clinical Oncology. ,vol. 29, pp. 4430- 4435 ,(2011) , 10.1200/JCO.2011.35.5750
Murielle E Mauer, Andrew Bottomley, Martin JB Taphoorn, Evaluating health-related quality of life and symptom burden in brain tumour patients : instruments for use in experimental trials and clinical practice Current Opinion in Neurology. ,vol. 21, pp. 745- 753 ,(2008) , 10.1097/WCO.0B013E328315EF7D
E. M. Sizoo, L. Braam, T. J. Postma, H. R. W. Pasman, J. J. Heimans, M. Klein, J. C. Reijneveld, M. J. B. Taphoorn, Symptoms and problems in the end-of-life phase of high-grade glioma patients Neuro-oncology. ,vol. 12, pp. 1162- 1166 ,(2010) , 10.1093/NEUONC/NOP045
David Macdonald, Gwendoline Kiebert, Michael Prados, Alfred Yung, Jeffrey Olson, Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life Cancer Investigation. ,vol. 23, pp. 138- 144 ,(2005) , 10.1081/CNV-200050453
Marilyn Bergner, Quality of life, health status, and clinical research. Medical Care. ,vol. 27, ,(1989) , 10.1097/00005650-198903001-00012